The influence of insulin and incretin-based therapies on renal tubular transport
2024

Effects of Insulin and Incretin Therapies on Kidney Function

publication Evidence: moderate

Author Information

Author(s): Rosati Erica, Di Giuseppe Gianfranco, Mezza Teresa, Ferraro Pietro Manuel

Primary Institution: Università degli Studi di Verona

Hypothesis

How do insulin and incretin-based therapies influence renal tubular transport?

Conclusion

Insulin and incretin therapies have significant but complex effects on renal tubular transport, influencing sodium and electrolyte handling.

Supporting Evidence

  • Insulin has a well-documented effect on sodium reabsorption in the kidneys.
  • GLP-1 receptor agonists may influence renal function through both receptor-dependent and independent mechanisms.
  • Chronic use of GLP-1 receptor agonists shows potential natriuretic effects in diabetic patients.

Takeaway

Insulin and certain diabetes medications can change how the kidneys handle salt and water, which is important for people with diabetes.

Limitations

The study highlights a lack of extensive research on the effects of incretin therapies on renal function, particularly in diabetic patients.

Digital Object Identifier (DOI)

10.1007/s40620-024-02048-w

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication